In the draft resolution, this portfolio wants to stop financing these products from public resources when they are written to people who do not need them. There are also 13 other drugs on the list that will no longer be paid in cash from the Benefit Plan.
A few days ago, the Ministry of Health published a draft resolution in which it seeks to ensure the continuity of drug price regulation policies. In a 13-page document, he explained what treatment methods and procedures he wants to stop paying with government resources. Among them are popular dietary supplements, which today, as this newspaper reported a few months ago, are appointed to hundreds of people who do not need them. (Read Los & # 39; Peros & # 39; on the market for nutritional supplements in Colombia)
For example, an analysis by the Administrator of the General Welfare System for Health (Adres) at the beginning of this year showed these distortions: the doctor prescribed 60,000 cans of Glucerna for one patient, Abbott's product is intended for people with diabetes. He also formulated 90,000 presentations of Osmolite (Abbott), a key for people with nutrient absorption problems. Another doctor indicated that he prescribed food for a student who played volleyball to gain weight. (Read the Standards that the pharmaceutical industry wants to stop in order for the new Minister of Health)
“These products were created, in principle, for clinical use. They were for people who had a limit on the consumption of solid food. But to motivate the rest of the population to buy them without needing them is a mistake. Nutrients must be purchased from natural products, a nutritionist and professor at the universities of Javeriana and Nacional told the Mercedes Mora newspaper.
“These products may endanger the health of those who use them, causing, for example, obesity, overweight, liver failure,” Minister Juan Pablo Uribe said today.
However, there is still a question that needs to be resolved, and this often worries nutritionists. How to regulate advertising of these products and their sale in pharmacies and pharmacies? This issue has not yet been resolved.
In the draft resolution, Minsalud also mentions several popular drugs (or combinations thereof). A mixture of acetaminophen and codeine is one of them. The combination of acetaminophen and hydrocodone is different. Both are often used to treat specific neuropathic pain.
This does not mean, as Uribe explained, that acetaminophen will be excluded from the Benefit Plan. “This is a special exemption proposal for a specific therapeutic use, against which there is no evidence of sufficient medical effectiveness,” he said.
“This is a methodology that begins with a review of scientific and technical data on various medicines and technologies that have evidence that they are ineffective and therefore should not be paid for by restoring the Health Benefits Plan,” he said.
Similarly, there are several ways in the document that this portfolio wants to limit. Artificial insemination is one of them. They can not be assigned to those who have unspecified cases of infertility or sterility. Cleaning towels are also included.
The Ministry of Health removed this list after the Technological Health Assessment (IETS), scientific societies and subject experts evaluated 41 technologies that were postulated to be excluded from the Benefits Plan. From this list, he chose 14, which, although included in the draft resolution, are not final. This portfolio will receive comments before January 4 and, after their evaluation, will make a decision.